Shares of Egalet Corporation (NASDAQ:EGLT) fell 0% during trading on Friday . The company traded as low as $1.06 and last traded at $1.08. 1,138,666 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 2,543,067 shares. The stock had previously closed at $1.08.
Several brokerages have commented on EGLT. Stifel Nicolaus lowered Egalet from a “buy” rating to a “hold” rating and set a $1.50 price objective for the company. in a research report on Wednesday. Gabelli lowered Egalet from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th. Finally, Cantor Fitzgerald set a $7.00 price objective on Egalet and gave the company a “buy” rating in a research report on Friday, December 15th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the stock. Egalet has a consensus rating of “Hold” and a consensus price target of $6.20.
The company has a debt-to-equity ratio of -3.43, a quick ratio of 2.68 and a current ratio of 2.73. The firm has a market cap of $46.90, a PE ratio of -0.32 and a beta of 0.44.
Egalet Company Profile
Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company’s products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology.
Receive News & Ratings for Egalet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Egalet and related companies with MarketBeat.com's FREE daily email newsletter.